Sumatriptan and Naproxen Sodium is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Sumatriptan Succinate; Naproxen Sodium.
Product ID | 65862-928_2cac6b99-d569-4bd7-9cc7-f53a75401514 |
NDC | 65862-928 |
Product Type | Human Prescription Drug |
Proprietary Name | Sumatriptan and Naproxen Sodium |
Generic Name | Sumatriptan And Naproxen Sodium |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-02-15 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA207457 |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM |
Active Ingredient Strength | 85 mg/1; mg/1 |
Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2018-02-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA207457 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2018-02-15 |
Ingredient | Strength |
---|---|
SUMATRIPTAN SUCCINATE | 85 mg/1 |
SPL SET ID: | f5203c66-0a40-4263-a237-b71e930e4697 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0378-8755 | Sumatriptan and Naproxen Sodium | sumatriptan and naproxen sodium |
16714-891 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |
47335-410 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |
65862-928 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |
71800-901 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |